HKSE - Delayed Quote HKD

HENGRUI PHARMA (1276.HK)

57.700
-0.300
(-0.52%)
At close: 4:08:29 PM GMT+8

Research Analysis

Revenue vs. Earnings

Revenue 7.21B
Earnings --

Q1'24

Q2'24

Q3'24

Q1'25

0
2B
4B
6B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

67.00
67.00 Average
57.700 Current
67.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts ----11
Avg. Estimate 001.151.3
Low Estimate 001.151.3
High Estimate 001.151.3
Year Ago EPS ------1.15

Revenue Estimate

Currency in CNY Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 112222
Avg. Estimate 6.67B8.72B30.86B34.82B
Low Estimate 6.67B8.72B29.67B30.65B
High Estimate 6.67B8.72B33.42B40.09B
Year Ago Sales 7.6B6.59B--30.86B
Sales Growth (year/est) -12.23%32.38%--12.81%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 001.151.3
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
1276.HK ------13.42%
S&P 500 13.08%2.49%7.56%13.96%

Related Tickers